Magnetic Resonance Imaging Evaluation of Urothelial Cell Carcinoma: Histopathological Correlation, Staging, and Treatment Planning
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Current Problems in Diagnostic Radiology
- Vol. 47 (1) , 28-41
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Potential and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in Kidney, Prostate, and Bladder Cancer Including Pelvic Lymph Node Staging: A Critical Analysis of the LiteratureEuropean Urology, 2012
- The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesionsBritish Journal of Radiology, 2011
- Prostatic urothelial carcinoma: is transurethral prostatectomy necessary before bacillus Calmette‐Guérin immunotherapy?BJU International, 2009
- PEComas: the past, the present and the futureVirchows Archiv, 2007
- Intravesical Instillations with Bacillus Calmette-Guérin for the Treatment of Carcinoma In Situ Involving Prostatic DuctsEuropean Urology, 2006
- Neoadjuvant Cisplatinum Based Combination Chemotherapy in Patients with Invasive Bladder Cancer: A Combined Analysis of Two Nordic StudiesEuropean Urology, 2004
- Neoadjuvant Chemotherapy for Transitional Cell Carcinoma of the Bladder: A Systematic Review and Meta-AnalysisJournal of Urology, 2004
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003
- GEMCITABINE PLUS CISPLATIN FOR ADVANCED TRANSITIONAL CELL CARCINOMA OF THE URINARY TRACT: A PHASE II MULTICENTER TRIALJournal of Urology, 2000
- Ureteroscopic Treatment and Surveillance of Upper Urinary Tract Transitional Cell CarcinomaJournal of Urology, 1997